Therapeutic Asset Ratings
13,157 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Capecitabine
Kidney Cancer
Oliver Jonas
P2
B
(62)
Carboplatin
Adult T-Cell Leukemia/Lymphoma
Actuate Therapeutics Inc.
P2
B
(62)
Carboplatin
Metastatic Malignant Neoplasm In The Brain
Fudan University
P2
B
(62)
Carboplatin
Metastatic Malignant Neoplasm
Revolution Medicines, Inc.
P2
B
(62)
Carboplatin
Prostate Adenocarcinoma
University of Washington
P2
B
(62)
cd22 car-transduced t cells
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P2
B
(62)
Cediranib
Fallopian Tube Cancer
Prof Gordon Jayson
P2
B
(62)
Celecoxib
Central Nervous System Neoplasm
Medical University of Vienna
P2
B
(62)
Celecoxib
Triple-Negative Breast Carcinoma
Université de Sherbrooke
P2
B
(62)
Cetuximab
Anaplastic Astrocytoma
University of Miami
P2
B
(62)
CIS-DIAMMINEDICHLOROPLATINUM II
Peritoneum Cancer
Unidade Local de Saúde São João
P2
B
(62)
Cladribine
Leukemia
M.D. Anderson Cancer Center
P2
B
(62)
Cle-100
Major Depressive Disorder
Clexio Biosciences Ltd.
P2
B
(62)
Clofarabine
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
P2
B
(62)
Cobimetinib
Malignant Pancreatic Neoplasm
N.N. Petrov National Medical Research Center of Oncology
P2
B
(62)
ct-868
Obesity Disorder
Carmot Therapeutics, Inc.
P2
B
(62)
Cyclophosphamide
Metastatic Malignant Neoplasm In The Brain
City of Hope Medical Center
P2
B
(62)
Cyclophosphamide
Essential Thrombocythemia
Thomas Jefferson University
P2
B
(62)
Cyclophosphamide
Myelodysplastic Syndrome With Excess Blasts-1
Masonic Cancer Center, University of Minnesota
P2
B
(62)
CYCLOSPORIN A
Sickle Cell Disease
City of Hope Medical Center
P2
B
(62)
CYTARABINE
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
B
(62)
CYTARABINE
Acute Myeloid Leukemia By FAB Classification
University of Nebraska
P2
B
(62)
CYTARABINE
Precursor B-Cell Acute Lymphoblastic Leukemia
Princess Maxima Center for Pediatric Oncology
P2
B
(62)
Dalzanemdor
Dementia
Supernus Pharmaceuticals, Inc.
P2
B
(62)
Defactinib
Non-Small Cell Lung Carcinoma
Verastem, Inc.
P2
B
(62)
Showing 1151 to 1175 of 13,157 assets
Previous
Page 47 of 527
Next